Skip to content

EFFICIENCY OF HEMOVIGILANCE MODULE TRAININGS GIVEN TO NURSES

EVALUATION OF THE EFFICIENCY OF HEMOVIGILANCE MODULE TRAININGS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05625672
Enrollment
125
Registered
2022-11-23
Start date
2022-04-25
Completion date
2022-07-08
Last updated
2022-11-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nurse's Role, Training Group, Sensitivity

Brief summary

The aim of the present study is to determine the effectiveness of hemovigilance module training given to nurses.

Detailed description

125 nurses from the clinic and intensive care units, who received the most intensive blood transfusion from two different hospitals, were included in the study as the intervention and control groups. The control group was not trained. Only the pretest was administered one week after the posttest. After the pre-test was applied to the nurses in the intervention group, five modules of training, which lasted four hours, were given using interactive methods. Five modules of training were prepared by the researcher. These five modules are the 1st module of training; definition of hemovigilance, its aims, the development of hemovigilance in the world and in Turkey, and legal legislation, Module 2; Donor selection, Blood donation Process, Phlebotomy and Donor reactions, Module 3; blood, blood transfusion, its purpose, properties of blood and blood components, Blood transfusion process, Module 4; acute and delayed transfusion reactions and management, Module 5; It consists of the national hemovigilance system, the organization of the hemovigilance system at the hospital level, Traceability, Trace-back from the Patient to the Donor, and Look-back from the Donor to the Patient. the training was over, the final test was administered. One month later, this test was repeated.

Interventions

OTHERTraining

Hemovigilance module training

Sponsors

Ankara Yildirim Beyazıt University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Masking description

None (Open Label)

Intervention model description

Randomized, parallel-group, placebo-controlled study

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

She/He voluntarily agrees to participate in the research, Working as a nurse in the clinic and intensive care unit where blood transfusions are the most, Working for at least 6 months,

Exclusion criteria

Nurses working in the emergency and operating rooms, in clinics where blood transfusion is not performed the most, Being a new nurse, On maternity leave and maternity leave, Having an external assignment, Nurses working in the polyclinic,

Design outcomes

Primary

MeasureTime frameDescription
Hemovigilance Information Form5 hours or 1 monthIt consists of fifteen questions about hemovigilance and hemovigilance system and definitions.
Information Form on Blood Transfusion Complications5 hours or 1 monthThis section consists of nine questions including transfusion complications.
Information Form on Blood Transfusion Applications5 hours or 1 monthThis section consists of sixteen questions including donor selection, questions about blood components, blood group and safe blood transfusion.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026